1-3 of 3
Fedor Kryukov, MD PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Neural Stem Cell Marker Nestin As a Novel Unfavorable Prognostic Biomarker for Multiple Myeloma

Hana Svachova, MD PhD, Lucie Rihova, MSc, PhD, Lenka Besse, PhD, Fedor Kryukov, MD PhD, Lenka Zahradova, MD PhD, Tomas Jelinek, MD, Katerina Gracova, MD, Jiri Jarkovsky, MSc, PhD, Roman Hájek
Journal: Blood
Blood (2016) 128 (22): 5608.
https://doi.org/10.1182/blood.V128.22.5608.5608
Published: 2016
Journal Articles

Gene Expression Profile of Circulating Myeloma Cells Reveals CD44 and CD97 (ADGRE5) Overexpression

Tereza Sevcikova, MSc, PhD, Fedor Kryukov, MD PhD, Lucie Brozova, MSc, Jana Filipova, MSc, Zuzana Kufova, MSc, Katerina Growkova, MSc., Renata Bezdekova, MSc, Pavel Nemec, MSc, PhD, Lucie Rihova, MSc, PhD, Jiri Jarkovsky, MSc, PhD, Roman Hajek, prof, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5639.
https://doi.org/10.1182/blood.V128.22.5639.5639
Published: 2016
Journal Articles

Copy Number Variants Modulation and Their Clinical Impact in Multiple Myeloma

Zuzana Kufova, Mgr, Lucie Brozova, Mgr, Pavel Nemec, PhD MSc, Jan Smetana, Mgr, PhD, Elena Kryukova, MD PhD, Jana Filipova, Mgr, Lenka Sedlarikova, MSc, Sabina Sevcikova, RNDr, PhD, Jiri Jarkovsky, MSc, PhD, Fedor Kryukov, MD PhD, Roman Hajek
Journal: Blood
Blood (2015) 126 (23): 5304.
https://doi.org/10.1182/blood.V126.23.5304.5304
Published: 2015